CEL-SCI Corporation (CVM)
USD 0.3
(43.2%)
USD 0.3
(43.2%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.31 Million USD | -5.7% |
| 2022 | 18.36 Million USD | -5.04% |
| 2021 | 19.33 Million USD | -7.08% |
| 2020 | 20.8 Million USD | -7.47% |
| 2019 | 22.48 Million USD | -23.99% |
| 2018 | 29.58 Million USD | 12.66% |
| 2017 | 26.26 Million USD | 109.18% |
| 2016 | 12.55 Million USD | -39.29% |
| 2015 | 20.67 Million USD | 135.32% |
| 2014 | 8.78 Million USD | 112.33% |
| 2013 | 4.13 Million USD | -54.22% |
| 2012 | 9.04 Million USD | -5.31% |
| 2011 | 9.54 Million USD | -4.06% |
| 2010 | 9.95 Million USD | -73.24% |
| 2009 | 37.18 Million USD | 866.49% |
| 2008 | 3.84 Million USD | -36.52% |
| 2007 | 6.06 Million USD | -42.74% |
| 2006 | 10.58 Million USD | 971.99% |
| 2005 | 987.31 Thousand USD | 357.13% |
| 2004 | 215.98 Thousand USD | -87.22% |
| 2003 | 1.69 Million USD | -37.61% |
| 2002 | 2.7 Million USD | 433.57% |
| 2001 | 507.72 Thousand USD | -40.09% |
| 2000 | 847.42 Thousand USD | 69.48% |
| 1999 | 500 Thousand USD | 25.0% |
| 1998 | 400 Thousand USD | -20.0% |
| 1997 | 500 Thousand USD | 66.67% |
| 1996 | 300 Thousand USD | -81.25% |
| 1995 | 1.6 Million USD | 14.29% |
| 1994 | 1.4 Million USD | 100.0% |
| 1993 | 700 Thousand USD | 40.0% |
| 1992 | 500 Thousand USD | -28.57% |
| 1991 | 700 Thousand USD | 40.0% |
| 1990 | 500 Thousand USD | 0.0% |
| 1989 | 500 Thousand USD | -28.57% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 15.59 Million USD | -0.94% |
| 2024 Q2 | 15.74 Million USD | -1.97% |
| 2024 Q1 | 16.05 Million USD | -7.24% |
| 2023 Q3 | 17.52 Million USD | -2.87% |
| 2023 Q1 | 17.96 Million USD | -2.15% |
| 2023 Q2 | 18.04 Million USD | 0.45% |
| 2023 FY | 17.31 Million USD | -5.7% |
| 2023 Q4 | 17.31 Million USD | -1.23% |
| 2022 Q1 | 18.32 Million USD | -5.25% |
| 2022 Q4 | 18.36 Million USD | 1.1% |
| 2022 Q3 | 18.16 Million USD | -4.58% |
| 2022 Q2 | 19.03 Million USD | 3.89% |
| 2022 FY | 18.36 Million USD | -5.04% |
| 2021 Q4 | 19.33 Million USD | -2.58% |
| 2021 Q3 | 19.84 Million USD | 4.28% |
| 2021 Q2 | 19.03 Million USD | -8.4% |
| 2021 Q1 | 20.77 Million USD | -0.15% |
| 2021 FY | 19.33 Million USD | -7.08% |
| 2020 Q3 | 23.01 Million USD | 2.27% |
| 2020 FY | 20.8 Million USD | -7.47% |
| 2020 Q1 | 22.53 Million USD | 0.22% |
| 2020 Q2 | 22.5 Million USD | -0.14% |
| 2020 Q4 | 20.8 Million USD | -9.6% |
| 2019 Q2 | 23.79 Million USD | 2.47% |
| 2019 FY | 22.48 Million USD | -23.99% |
| 2019 Q4 | 22.48 Million USD | -17.74% |
| 2019 Q3 | 27.33 Million USD | 14.87% |
| 2019 Q1 | 23.22 Million USD | -21.5% |
| 2018 Q1 | 27 Million USD | 2.84% |
| 2018 FY | 29.58 Million USD | 12.66% |
| 2018 Q4 | 29.58 Million USD | 28.9% |
| 2018 Q3 | 22.95 Million USD | -12.22% |
| 2018 Q2 | 26.14 Million USD | -3.18% |
| 2017 Q2 | 11.8 Million USD | 114.79% |
| 2017 FY | 26.26 Million USD | 109.18% |
| 2017 Q4 | 26.26 Million USD | 91.04% |
| 2017 Q3 | 13.74 Million USD | 16.48% |
| 2017 Q1 | 5.49 Million USD | -56.23% |
| 2016 FY | 12.55 Million USD | -39.29% |
| 2016 Q1 | 16.45 Million USD | -20.43% |
| 2016 Q2 | 18.45 Million USD | 12.18% |
| 2016 Q3 | 18.25 Million USD | -1.1% |
| 2016 Q4 | 12.55 Million USD | -31.23% |
| 2015 Q2 | 12.38 Million USD | 60.52% |
| 2015 Q4 | 20.67 Million USD | 17.69% |
| 2015 Q3 | 17.56 Million USD | 41.88% |
| 2015 Q1 | 7.71 Million USD | -12.21% |
| 2015 FY | 20.67 Million USD | 135.32% |
| 2014 Q1 | 9.68 Million USD | 134.02% |
| 2014 Q2 | 14.46 Million USD | 49.33% |
| 2014 FY | 8.78 Million USD | 112.33% |
| 2014 Q4 | 8.78 Million USD | -13.18% |
| 2014 Q3 | 10.12 Million USD | -30.02% |
| 2013 Q1 | 10.39 Million USD | 14.94% |
| 2013 Q4 | 4.13 Million USD | -40.47% |
| 2013 Q3 | 6.95 Million USD | 0.1% |
| 2013 Q2 | 6.94 Million USD | -33.16% |
| 2013 FY | 4.13 Million USD | -54.22% |
| 2012 Q4 | 9.04 Million USD | -17.15% |
| 2012 Q2 | 12.14 Million USD | 41.75% |
| 2012 Q1 | 8.56 Million USD | -10.27% |
| 2012 FY | 9.04 Million USD | -5.31% |
| 2012 Q3 | 10.91 Million USD | -10.13% |
| 2011 FY | 9.54 Million USD | -4.06% |
| 2011 Q4 | 9.54 Million USD | -34.43% |
| 2011 Q3 | 14.55 Million USD | -27.64% |
| 2011 Q2 | 20.12 Million USD | 78.28% |
| 2011 Q1 | 11.28 Million USD | 13.42% |
| 2010 Q3 | 7.42 Million USD | -28.35% |
| 2010 Q4 | 9.95 Million USD | 33.99% |
| 2010 FY | 9.95 Million USD | -73.24% |
| 2010 Q2 | 10.36 Million USD | -30.21% |
| 2010 Q1 | 14.84 Million USD | -60.07% |
| 2009 Q3 | 7.64 Million USD | 74.69% |
| 2009 Q1 | 3.48 Million USD | -9.39% |
| 2009 Q2 | 4.37 Million USD | 25.46% |
| 2009 Q4 | 37.18 Million USD | 386.65% |
| 2009 FY | 37.18 Million USD | 866.49% |
| 2008 Q1 | 4.94 Million USD | -18.4% |
| 2008 Q2 | 6.48 Million USD | 31.22% |
| 2008 Q3 | 5.5 Million USD | -15.11% |
| 2008 Q4 | 3.84 Million USD | -30.16% |
| 2008 FY | 3.84 Million USD | -36.52% |
| 2007 Q1 | 10.24 Million USD | -3.23% |
| 2007 Q2 | 10.69 Million USD | 4.4% |
| 2007 FY | 6.06 Million USD | -42.74% |
| 2007 Q4 | 6.06 Million USD | -20.49% |
| 2007 Q3 | 7.62 Million USD | -28.71% |
| 2006 FY | 10.58 Million USD | 971.99% |
| 2006 Q2 | 311.27 Thousand USD | 30.89% |
| 2006 Q4 | 10.58 Million USD | 4042.95% |
| 2006 Q3 | 255.46 Thousand USD | -17.93% |
| 2006 Q1 | 237.81 Thousand USD | -75.91% |
| 2005 Q2 | 236.68 Thousand USD | -27.59% |
| 2005 Q4 | 987.31 Thousand USD | 276.74% |
| 2005 FY | 987.31 Thousand USD | 357.13% |
| 2005 Q1 | 326.87 Thousand USD | 51.35% |
| 2005 Q3 | 262.06 Thousand USD | 10.72% |
| 2004 Q3 | 305.25 Thousand USD | -36.87% |
| 2004 Q4 | 215.98 Thousand USD | -29.25% |
| 2004 FY | 215.98 Thousand USD | -87.22% |
| 2004 Q2 | 483.56 Thousand USD | 34.82% |
| 2004 Q1 | 358.67 Thousand USD | -78.78% |
| 2003 Q2 | 2.12 Million USD | 0.05% |
| 2003 Q1 | 2.12 Million USD | -21.56% |
| 2003 FY | 1.69 Million USD | -37.61% |
| 2003 Q4 | 1.69 Million USD | -5.24% |
| 2003 Q3 | 1.78 Million USD | -16.11% |
| 2002 Q3 | 2 Million USD | -1.73% |
| 2002 Q1 | 2.21 Million USD | 336.94% |
| 2002 Q4 | 2.7 Million USD | 35.15% |
| 2002 Q2 | 2.03 Million USD | -8.05% |
| 2002 FY | 2.7 Million USD | 433.57% |
| 2001 Q1 | 789.85 Thousand USD | -6.79% |
| 2001 Q4 | 507.72 Thousand USD | 18.93% |
| 2001 Q3 | 426.89 Thousand USD | 4.18% |
| 2001 FY | 507.72 Thousand USD | -40.09% |
| 2001 Q2 | 409.78 Thousand USD | -48.12% |
| 2000 Q4 | 847.42 Thousand USD | 64.05% |
| 2000 Q1 | 300 Thousand USD | -40.0% |
| 2000 Q3 | 516.56 Thousand USD | -13.21% |
| 2000 FY | 847.42 Thousand USD | 69.48% |
| 2000 Q2 | 595.17 Thousand USD | 98.39% |
| 1999 Q4 | 500 Thousand USD | 150.0% |
| 1999 Q3 | 200 Thousand USD | -50.0% |
| 1999 Q2 | 400 Thousand USD | 33.33% |
| 1999 FY | 500 Thousand USD | 25.0% |
| 1999 Q1 | 300 Thousand USD | -25.0% |
| 1998 FY | 400 Thousand USD | -20.0% |
| 1998 Q4 | 400 Thousand USD | 33.33% |
| 1998 Q3 | 300 Thousand USD | 200.0% |
| 1998 Q2 | 100 Thousand USD | -75.0% |
| 1998 Q1 | 400 Thousand USD | -20.0% |
| 1997 Q3 | 400 Thousand USD | 0.0% |
| 1997 Q1 | 600 Thousand USD | 100.0% |
| 1997 FY | 500 Thousand USD | 66.67% |
| 1997 Q4 | 500 Thousand USD | 25.0% |
| 1997 Q2 | 400 Thousand USD | -33.33% |
| 1996 FY | 300 Thousand USD | -81.25% |
| 1996 Q2 | 2.3 Million USD | 155.56% |
| 1996 Q3 | 1.2 Million USD | -47.83% |
| 1996 Q4 | 300 Thousand USD | -75.0% |
| 1996 Q1 | 900 Thousand USD | -43.75% |
| 1995 FY | 1.6 Million USD | 14.29% |
| 1995 Q3 | 1.4 Million USD | 0.0% |
| 1995 Q1 | 1.3 Million USD | -7.14% |
| 1995 Q2 | 1.4 Million USD | 7.69% |
| 1995 Q4 | 1.6 Million USD | 14.29% |
| 1994 FY | 1.4 Million USD | 100.0% |
| 1994 Q4 | 1.4 Million USD | 133.33% |
| 1994 Q3 | 600 Thousand USD | 50.0% |
| 1994 Q2 | 400 Thousand USD | -20.0% |
| 1994 Q1 | 500 Thousand USD | -28.57% |
| 1993 Q3 | 500 Thousand USD | 25.0% |
| 1993 Q4 | 700 Thousand USD | 40.0% |
| 1993 FY | 700 Thousand USD | 40.0% |
| 1993 Q1 | 500 Thousand USD | 0.0% |
| 1993 Q2 | 400 Thousand USD | -20.0% |
| 1992 Q1 | 300 Thousand USD | -57.14% |
| 1992 Q2 | 200 Thousand USD | -33.33% |
| 1992 Q3 | 100 Thousand USD | -50.0% |
| 1992 Q4 | 500 Thousand USD | 400.0% |
| 1992 FY | 500 Thousand USD | -28.57% |
| 1991 FY | 700 Thousand USD | 40.0% |
| 1991 Q4 | 700 Thousand USD | 40.0% |
| 1991 Q2 | 600 Thousand USD | 20.0% |
| 1991 Q3 | 500 Thousand USD | -16.67% |
| 1991 Q1 | 500 Thousand USD | 0.0% |
| 1990 Q2 | 600 Thousand USD | 50.0% |
| 1990 Q4 | 500 Thousand USD | 0.0% |
| 1990 FY | 500 Thousand USD | 0.0% |
| 1990 Q1 | 400 Thousand USD | -20.0% |
| 1990 Q3 | 500 Thousand USD | -16.67% |
| 1989 Q3 | 500 Thousand USD | 0.0% |
| 1989 Q4 | 500 Thousand USD | 0.0% |
| 1989 FY | 500 Thousand USD | -28.57% |
| 1989 Q1 | 500 Thousand USD | -28.57% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AIM ImmunoTech Inc. | 9.14 Million USD | -89.279% |
| Ampio Pharmaceuticals, Inc. | 2.37 Million USD | -628.677% |
| Armata Pharmaceuticals, Inc. | 142.02 Million USD | 87.81% |
| Actinium Pharmaceuticals, Inc. | 45.06 Million USD | 61.582% |
| Azitra, Inc. | 2.2 Million USD | -686.135% |
| Can-Fite BioPharma Ltd. | 3.74 Million USD | -362.183% |
| Chromocell Therapeutics Corporation | 6.54 Million USD | -164.692% |
| Calidi Biotherapeutics, Inc. | 18.25 Million USD | 5.153% |
| iBio, Inc. | 7.41 Million USD | -133.649% |
| Lineage Cell Therapeutics, Inc. | 38.99 Million USD | 55.602% |
| MAIA Biotechnology, Inc. | 7.08 Million USD | -144.217% |
| Matinas BioPharma Holdings, Inc. | 46.33 Million USD | 62.632% |
| Navidea Biopharmaceuticals, Inc. | 12.51 Million USD | -38.342% |
| NovaBay Pharmaceuticals, Inc. | 5.72 Million USD | -202.681% |
| NanoViricides, Inc. | 1.35 Million USD | -1174.188% |
| Oragenics, Inc. | 1.79 Million USD | -862.826% |
| BiomX Inc. | 55.07 Million USD | 68.564% |
| BiomX Inc. | 55.07 Million USD | 68.564% |
| Protalix BioTherapeutics, Inc. | 50.86 Million USD | 65.962% |
| Palatin Technologies, Inc. | 10.85 Million USD | -59.515% |
| Scorpius Holdings, Inc. | 22.74 Million USD | 23.875% |
| Theriva Biologics, Inc. | 20.51 Million USD | 15.602% |